<P><p>The portal currently contains data from the following TCGA cancer genomics studies. The table below lists the number of available samples per data type and tumor.<br><br>
<table border="1" cellpadding="2" cellspacing="0" style="border-collapse: collapse" bordercolor="#808080">
	<tr>
		<th width=75>Cancer</th>
		<th width=225>Full cancer name</th>
		<th width=75>Sequenced</th>
		<th width=75>aCGH</th>
		<th width=75>Normal mRNA</th>
		<th width=75>Tumor mRNA</th>
		<th width=75>Complete</th>
		<th width=75>All</th>
	</tr>

	<tr class="rowcolor">
		<td><b>BRCA</b></td>
		<td><b>Breast invasive carcinoma (TCGA)</b></td>
		<td>700</td>
		<td>527</td>
		<td>0</td>
		<td>530</td>
		<td>498</td>
		<td><b>727</b></td>
	</tr>

	<tr>
		<td><b>Breast Cancer Cell Line</b></td>
		<td><b>SU2C Breast Cancer Cell Line Data (Gray Lab)</b></td>
		<td>0</td>
		<td>53</td>
		<td>0</td>
		<td>55</td>
		<td>53</td>
		<td><b>55</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>OV</b></td>
		<td><b>Ovarian serous cystadenocarcinoma (TCGA)</b></td>
		<td>316</td>
		<td>489</td>
		<td>10</td>
		<td>489</td>
		<td>316</td>
		<td><b>489</b></td>
	</tr>

	<tr>
		<td><b>UCEC</b></td>
		<td><b>Uterine Corpus Endometrioid Carcinoma (TCGA)</b></td>
		<td>283</td>
		<td>237</td>
		<td>0</td>
		<td>54</td>
		<td>53</td>
		<td><b>284</b></td>
	</tr>

</table>
